Patents by Inventor Steve Arsenault

Steve Arsenault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190197375
    Abstract: The invention relates to traceable metallic products, methods of uses and methods of making same. The metallic products may be made traceable for integrity purposes, identification purposes, counterfeit avoidance and the like. The invention also relates to metallic supports for nanostorage of various compounds and samples.
    Type: Application
    Filed: January 11, 2019
    Publication date: June 27, 2019
    Inventors: Steve Arsenault, Daniel Gaudet, Daniel Rivard, Maxime Dumont, Jocelyn Lambert
  • Publication number: 20160267368
    Abstract: The invention relates to traceable metallic products, methods of uses and methods of making same. The metallic products may be made traceable for integrity purposes, identification purposes, counterfeit avoidance and the like. The invention also relates to metallic supports for nanostorage of various compounds and samples.
    Type: Application
    Filed: October 17, 2014
    Publication date: September 15, 2016
    Applicant: 9163-0384 Quebec Inc.
    Inventors: Steve ARSENAULT, Daniel GAUDET, Daniel RIVARD, Maxime DUMONT, Jocelyn LAMBERT
  • Publication number: 20080319176
    Abstract: Novel alterations in the glycerol kinase gene are described. Also described are methods of predicting or assisting in the prediction of impaired glucose tolerance and type 2 diabetes mellitus.
    Type: Application
    Filed: February 25, 2008
    Publication date: December 25, 2008
    Inventors: Daniel Gaudet, John D. Rioux, Steve Arsenault, Thomas J. Hudson, Mark Daly
  • Publication number: 20040259134
    Abstract: Novel alterations in the glycerol kinase gene are described. Also described are methods of predicting or assisting in the prediction of impaired glucose tolerance and type 2 diabetes mellitus.
    Type: Application
    Filed: April 19, 2004
    Publication date: December 23, 2004
    Applicants: Whitehead Institute for Biomedical Research, Complexe Hospitalier de la Sagamie
    Inventors: Daniel Gaudet, John D. Rioux, Steve Arsenault, Thomas J. Hudson, Mark J. Daly
  • Patent number: 6743579
    Abstract: Novel alterations in the glycerol kinase gene are described. Also described are methods of predicting or assisting in the prediction of impaired glucose tolerance and type 2 diabetes mellitus.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: June 1, 2004
    Assignees: Whitehead Institute for Biomedical Research, Complexe Hospitalier de la Sagamie
    Inventors: Daniel Gaudet, John D. Rioux, Steve Arsenault, Thomas J. Hudson, Mark Daly